Peptone supplementation to increase productivity and reduce serum use in vaccine manufacturing
Syed Muaz Khalil, Chris Titensor
De-risking Phase I/II trials for emerging biotech innovators
J Gordon, L Timmerman, D Schaumberg et al
Controlled human infection models in vaccine development: what’s new in 2025?
M B. Laurens, A P. Durbin, M Cavaleri et al
Achieving high-quality, efficient mRNA synthesis for streamlined and cost-effective manufacturing
Helge Zieler, Khaled Yamout
Faster, smaller, smarter: intelligent manufacturing of mRNA through the power of process analytical technologies
Aaron Cowley, Edita Botonjic-Sehic